CHINA PHARMA HOLDINGS, INC. Deferred Income Tax Liabilities, Net
CHINA PHARMA HOLDINGS, INC. (CPHI) had Deferred Income Tax Liabilities, Net of $771.73 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-14
- 2026-06-30: Deferred Income Tax Liabilities, Net $771.73K.
- 2026-03-31: Deferred Income Tax Liabilities, Net $759.63K.
- 2025-12-31: Deferred Income Tax Liabilities, Net $747.80K.
- 2025-09-30: Deferred Income Tax Liabilities, Net $739.73K.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $771.73K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $759.63K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $747.80K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $739.73K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $734.25K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $732.24K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $731.20K 10-K · filed 2026-04-01 |
| 2024-09-30 | $750.09K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $737.52K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $742.11K 10-K · filed 2025-03-31 |
| 2023-09-30 | $732.08K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $727.42K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $764.90K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $754.70K 10-K · filed 2024-04-01 |
| 2022-09-30 | $740.33K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $783.17K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $827.98K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $824.41K 10-K · filed 2023-03-30 |
| 2021-09-30 | $810.46K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $813.64K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $799.87K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $805.56K 10-K · filed 2022-03-30 |
| 2020-09-30 | $771.82K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $742.45K 10-Q · filed 2020-08-13 |
| 2019-12-31 | $753.44K 10-K · filed 2021-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |